Skip to main content
Download PDF

Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology

Translational Neurodegeneration volume 12, Article number: 2 (2023) Cite this article

The Original Article was published on 28 December 2022

Correction: Translational Neurodegeneration (2022) 11:58 https://doi.org/10.1186/s40035-022-00329-7

Following publication of this article [1], the authors identified an error in the family name of Alon Monsonego.

The incorrect author name is: Alon Monsengo.

The correct author name is: Alon Monsonego.

The author group has been updated above and the original article [1] has been corrected.

Reference

  1. Verma, et al. Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology. Transl Neurodegener. 2022;11:58.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Alberto Ouro

    Present address: NeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain

  2. Ankit Verma and Anna Shteinfer-Kuzmine have contributed equally to this work

Authors and Affiliations

  1. Department of Life Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel

    Ankit Verma, Nikita Kamenetsky, Srinivas Pittala, Avijit Paul, Noga Vardi & Varda Shoshan-Barmatz

  2. National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel

    Ankit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, Srinivas Pittala, Avijit Paul, Swaroop Kumar Pandey, Shira Knafo & Varda Shoshan-Barmatz

  3. Achva Academic College, 79804, Shikmim, Israel

    Edna Nahon Crystal

  4. Department of Physiology, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel

    Alberto Ouro & Shira Knafo

  5. Ilse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel

    Vered Chalifa-Caspi

  6. The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel

    Alon Monsonego

Authors
  1. Ankit Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Shteinfer-Kuzmine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikita Kamenetsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Srinivas Pittala
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Avijit Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edna Nahon Crystal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alberto Ouro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vered Chalifa-Caspi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Swaroop Kumar Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Alon Monsonego
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Noga Vardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shira Knafo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Varda Shoshan-Barmatz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Varda Shoshan-Barmatz.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verma, A., Shteinfer-Kuzmine, A., Kamenetsky, N. et al. Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology. Transl Neurodegener 12, 2 (2023). https://doi.org/10.1186/s40035-023-00335-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40035-023-00335-3

Translational Neurodegeneration

ISSN: 2047-9158

Contact us